Zhejiang Orient Gene Biotech Co., Ltd (SHA:688298)

China flag China · Delayed Price · Currency is CNY
19.32
-0.24 (-1.23%)
Jun 11, 2026, 2:24 PM CST
Market Cap3.78B -17.1%
Revenue (ttm)1.01B +20.9%
Net Income-551.99M
EPS-2.91
Shares Out 193.20M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,004,207
Open19.70
Previous Close19.56
Day's Range19.05 - 19.70
52-Week Range19.10 - 30.65
Beta0.82
Analystsn/a
Price Targetn/a
Earnings DateAug 28, 2026

About SHA:688298

Zhejiang Orient Gene Biotech Co., Ltd researches and develops, produces, and sells in vitro diagnostic products worldwide. Its products include POCT instant diagnostic reagents, used for detection of infectious diseases, drugs of abuse, fertility, tumor marker, and cardiac marker detection. The company offers its products for various categories, including COVID-19 diagnosis solutions; immunological diagnosis; quantum-beads flowcytometry; instrument; dry biochemical strips; raw materials; FISH probes; animal health; biochemistry; molecular diagn... [Read more]

Sector Healthcare
Founded 2005
Employees 2,434
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688298
Full Company Profile

Financial Performance

In 2025, SHA:688298's revenue was 947.38 million, an increase of 14.43% compared to the previous year's 827.92 million. Losses were -573.60 million, 8.43% more than in 2024.

Financial Statements